Teicoplanin induced drug hypersensitivity syndrome

British Medical Journal

Volumn 328, Issue 7451, 2004, Pages 1292-

  Perrett, C M ^a   McBride, S R ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CLARITHROMYCIN; ETRETIN; FLUCLOXACILLIN; METHOTREXATE; PENICILLIN G; PREDNISOLONE; STEROID; TEICOPLANIN;

ADULT; BACTERIAL INFECTION; CASE REPORT; CELLULITIS; CLINICAL FEATURE; DRUG FEVER; DRUG HYPERSENSITIVITY; EOSINOPHILIA; HUMAN; LYMPHADENOPATHY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; PRIORITY JOURNAL; PSORIASIS; PUSTULAR PSORIASIS; SHORT SURVEY; SIDE EFFECT; URTICARIA;

EID: 2542538245     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7451.1292     Document Type: Short Survey

References (3)

1. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs.4 N Engl J Med 1994;331:1272-85.
2. Sullivan J, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001;137:357-63.
3. Davey PG, Williams AH. A review of the safety profile of teicoplanin. J Antimicrob Chemother 1991;27(suppl B):69-73.